Literature DB >> 12461035

The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland.

Jolanta Krzysztoń-Russjan1, Marek Gniadkowski, Hanna Połowniak-Pracka, Elzbieta Hagmajer, Waleria Hryniewicz.   

Abstract

The first heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) isolates to be identified in Poland were characterized. They were recovered in two Warsaw hospitals and, although in one of these the identification coincided with unsuccessful glycopeptide therapy, the selection conditions and clinical significance of the organisms remain unclear. Molecular typing revealed that the isolates were closely related and belonged to an international methicillin-resistant S. aureus (MRSA) clone known as 'Iberian'. The analysis of epidemiologically related MRSA isolates and some archival Polish MRSA isolates of the same clone indicated that the hVISA phenotype has been present in the MRSA populations of some hospitals in Poland since at least 1998.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461035     DOI: 10.1093/jac/dkf252

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

Review 1.  Current diagnostic tools for methicillin-resistant Staphylococcus aureus infections.

Authors:  Julianna Kurlenda; Mariusz Grinholc
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

2.  Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998.

Authors:  Hilmar Wisplinghoff; Birgitta Ewertz; Susanne Wisplinghoff; Danuta Stefanik; Georg Plum; Francoise Perdreau-Remington; Harald Seifert
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 3.  Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection.

Authors:  M H Kollef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

4.  Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins.

Authors:  Agnieszka Luczak-Kadlubowska; Jolanta Krzyszton-Russjan; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

5.  Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland.

Authors:  Agnieszka Łuczak-Kadłubowska; Agnieszka Sulikowska; Joanna Empel; Anna Piasecka; Monika Orczykowska; Aleksandra Kozinska; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

Review 6.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.

Authors:  Aref Shariati; Masoud Dadashi; Majid Taati Moghadam; Alex van Belkum; Somayeh Yaslianifard; Davood Darban-Sarokhalil
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

8.  Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland.

Authors:  Ksenia Szymanek-Majchrzak; Andrzej Mlynarczyk; Grazyna Mlynarczyk
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-29       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.